Vicente E. Torres

Department of Internal Medicine, Mayo Clinic

Research Area

Biography

Vicente E. Torres has not added Biography.
If you are Vicente E. Torres and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 13	2015

Other Publications

Article	Year
Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats. Kidney international\| PubMed ID: 15496147	2004
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nature genetics\| PubMed ID: 11919560	2002
The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. Journal of the American Society of Nephrology : JASN\| PubMed ID: 11961010	2002
A complete mutation screen of the ADPKD genes by DHPLC. Kidney international\| PubMed ID: 11967008	2002
Clinical profile of autosomal dominant polycystic liver disease. Hepatology (Baltimore, Md.)\| PubMed ID: 12500201	2003
The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1. American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 12500225	2003
Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. American journal of human genetics\| PubMed ID: 12529853	2003
PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression. Human molecular genetics\| PubMed ID: 12620974	2003
Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet (London, England)\| PubMed ID: 12842373	2003
A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney international\| PubMed ID: 12846734	2003
Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Human molecular genetics\| PubMed ID: 12874107	2003
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney international\| PubMed ID: 12911554	2003
Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Human molecular genetics\| PubMed ID: 12925574	2003
Analysis of the polycystins in aortic vascular smooth muscle cells. Journal of the American Society of Nephrology : JASN\| PubMed ID: 12937304	2003
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nature medicine\| PubMed ID: 14502283	2003
EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney international\| PubMed ID: 14531789	2003
Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology\| PubMed ID: 14598246	2003
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. Kidney international\| PubMed ID: 14633145	2003
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nature medicine\| PubMed ID: 14991049	2004
Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney international\| PubMed ID: 15086900	2004
Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nature genetics\| PubMed ID: 15133510	2004
Therapies to slow polycystic kidney disease. Nephron. Experimental nephrology\| PubMed ID: 15361692	2004
Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease. The American journal of pathology\| PubMed ID: 15509540	2004
Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease. American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 15696446	2005
Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. Journal of the American Society of Nephrology : JASN\| PubMed ID: 15728778	2005
[Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype. Circulation research\| PubMed ID: 15790956	2005
Vasopressin antagonists in polycystic kidney disease. Kidney international\| PubMed ID: 16221255	2005
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 16310571	2005
The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat. Nature genetics\| PubMed ID: 16415887	2006
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease ... Journal of the American Society of Nephrology : JASN\| PubMed ID: 16452494	2006
Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine\| PubMed ID: 16523049	2006
Volume progression in polycystic kidney disease. The New England journal of medicine\| PubMed ID: 16707749	2006
Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy. Current opinion in nephrology and hypertension\| PubMed ID: 16775462	2006
Water for ADPKD? Probably, yes. Journal of the American Society of Nephrology : JASN\| PubMed ID: 16837639	2006
Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference. The Journal of pediatrics\| PubMed ID: 16887426	2006
Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases. Nature clinical practice. Nephrology\| PubMed ID: 16932388	2006
Duodenal diverticulosis in autosomal dominant polycystic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association\| PubMed ID: 16951424	2006
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology : JASN\| PubMed ID: 17035604	2006
Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis. Journal of nephrology\| PubMed ID: 17048214	2006
Cerebral aneurysms. The New England journal of medicine\| PubMed ID: 17186587	2006
Molecular diagnostics of Meckel-Gruber syndrome highlights phenotypic differences between MKS1 and MKS3. Human genetics\| PubMed ID: 17377820	2007
Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. Gastroenterology\| PubMed ID: 17383431	2007
Retinal arterial and venous occlusions in patients with ADPKD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association\| PubMed ID: 17403703	2007
Autosomal dominant polycystic kidney disease. Lancet (London, England)\| PubMed ID: 17434405	2007
Inferior vena cava stenting: a safe and effective treatment for intractable ascites in patients with polycystic liver disease. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract\| PubMed ID: 17508255	2007
Treatment of polycystic liver disease: one size does not fit all. American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 17533013	2007
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology : JASN\| PubMed ID: 17582161	2007
Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magnetic resonance in medicine\| PubMed ID: 17654577	2007
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohor... Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 17699192	2006
Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 17699202	2006
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 17699395	2007
Increased occurrence of pericardial effusion in patients with autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 17928471	2007
Vasopressin directly regulates cyst growth in polycystic kidney disease. Journal of the American Society of Nephrology : JASN\| PubMed ID: 18032793	2008
Sirolimus reduces polycystic liver volume in ADPKD patients. Journal of the American Society of Nephrology : JASN\| PubMed ID: 18199797	2008
Role of vasopressin antagonists. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 18434616	2008
Vasopressin antagonists in polycystic kidney disease. Seminars in nephrology\| PubMed ID: 18519091	2008
What the similarities of specific polycystic liver and kidney diseases can teach us about both. Nephrology news & issues\| PubMed ID: 18778002	2008
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney international\| PubMed ID: 18818683	2008
Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association\| PubMed ID: 18826972	2009
Polycystic kidney disease. Annual review of medicine\| PubMed ID: 18947299	2009
Characterization of PKD protein-positive exosome-like vesicles. Journal of the American Society of Nephrology : JASN\| PubMed ID: 19158352	2009
Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney international\| PubMed ID: 19165178	2009
MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 19339416	2009
A case for water in the treatment of polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 19443627	2009
Autosomal dominant polycystic kidney disease: the last 3 years. Kidney international\| PubMed ID: 19455193	2009
Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3. Human molecular genetics\| PubMed ID: 19515853	2009
Type II calcimimetics and polycystic kidney disease: unanswered questions. Journal of the American Society of Nephrology : JASN\| PubMed ID: 19520753	2009
Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Annals of surgery\| PubMed ID: 19561475	2009
Vasopressin in chronic kidney disease: an elephant in the room? Kidney international\| PubMed ID: 19829311	2009
Percutaneous nephrolithotomy for large or multiple upper tract calculi and autosomal dominant polycystic kidney disease. The Journal of urology\| PubMed ID: 19913818	2010
Cyclic nucleotide signaling in polycystic kidney disease. Kidney international\| PubMed ID: 19924104	2010
The HALT polycystic kidney disease trials: design and implementation. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 20089507	2010
Treatment strategies and clinical trial design in ADPKD. Advances in chronic kidney disease\| PubMed ID: 20219622	2010
Renal arterial blood flow measurement by breath-held MRI: Accuracy in phantom scans and reproducibility in healthy subjects. Magnetic resonance in medicine\| PubMed ID: 20373395	2010
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. Journal of the American Society of Nephrology : JASN\| PubMed ID: 20431041	2010
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 20498248	2010
Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. Journal of the American Society of Nephrology : JASN\| PubMed ID: 20558538	2010
Genetic variation of DKK3 may modify renal disease severity in ADPKD. Journal of the American Society of Nephrology : JASN\| PubMed ID: 20616171	2010
Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 20966119	2011
Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease. PPAR research\| PubMed ID: 21052534	2010
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 21088290	2011
Medical and surgical treatment options for polycystic liver disease. Hepatology (Baltimore, Md.)\| PubMed ID: 21105111	2010
Germline PKHD1 mutations are protective against colorectal cancer. Human genetics\| PubMed ID: 21274727	2011
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 21333426	2011
Short-term reproducibility of ambulatory blood pressure monitoring in autosomal dominant polycystic kidney disease. Blood pressure monitoring\| PubMed ID: 21415814	2011
B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis. Human molecular genetics\| PubMed ID: 21493627	2011
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease. Kidney international\| PubMed ID: 21544064	2011
Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 21551026	2011
Frequency of undiagnosed cystic lung disease in patients with sporadic renal angiomyolipomas. Chest\| PubMed ID: 21737494	2012
Fibrosis, regeneration, and aging: playing chess with evolution. Journal of the American Society of Nephrology : JASN\| PubMed ID: 21757767	2011
Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 21903983	2011
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 21903984	2011
Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of fibrocystin. Journal of the American Society of Nephrology : JASN\| PubMed ID: 22021705	2011
Polycystic kidney disease in 2011: Connecting the dots toward a polycystic kidney disease therapy. Nature reviews. Nephrology\| PubMed ID: 22158473	2012
Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney international\| PubMed ID: 22205355	2012
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 22344503	2012
Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. Journal of the American Society of Nephrology : JASN\| PubMed ID: 22383692	2012
Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors. American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 22398108	2012
Somatostatin analog therapy for severe polycystic liver disease: results after 2 years. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association\| PubMed ID: 22773240	2012
Insignificant effect of secretin in rodent models of polycystic kidney and liver disease. American journal of physiology. Renal physiology\| PubMed ID: 22811488	2012
Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation. Transplantation\| PubMed ID: 22820698	2012
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. The Journal of clinical investigation\| PubMed ID: 23064367	2012
Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CR... American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 23089511	2013
Tolvaptan in patients with autosomal dominant polycystic kidney disease. The New England journal of medicine\| PubMed ID: 23121377	2012
Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases. Hepatology (Baltimore, Md.)\| PubMed ID: 23172758	2013
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PloS one\| PubMed ID: 23326375	2013
Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. Journal of molecular and cellular cardiology\| PubMed ID: 23376035	2013
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 23520042	2013
Tolvaptan in autosomal dominant polycystic kidney disease. The New England journal of medicine\| PubMed ID: 23534568	2013
Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association\| PubMed ID: 23543593	2013
Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data. Gastroenterology\| PubMed ID: 23665274	2013
Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease. Current opinion in nephrology and hypertension\| PubMed ID: 23736843	2013
Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families. Kidney international\| PubMed ID: 23760289	2014
Experimental therapies and ongoing clinical trials to slow down progression of ADPKD. Current hypertension reviews\| PubMed ID: 23971644	2013
Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease. American journal of nephrology\| PubMed ID: 24107679	2013
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study. American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 24183837	2014
Transition fibre protein FBF1 is required for the ciliary entry of assembled intraflagellar transport complexes. Nature communications\| PubMed ID: 24231678	2013
Evaluating health-related quality of life in patients with polycystic liver disease and determining the impact of symptoms and liver volume. Liver international : official journal of the International Association for the Study of the Liver\| PubMed ID: 24313956	2014
Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. Journal of the American Society of Nephrology : JASN\| PubMed ID: 24335972	2014
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney dis... American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 24342522	2014
Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD. American journal of physiology. Renal physiology\| PubMed ID: 24370592	2014
Novel methodology to evaluate renal cysts in polycystic kidney disease. American journal of nephrology\| PubMed ID: 24576800	2014
The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation. Journal of the American Society of Nephrology : JASN\| PubMed ID: 24578126	2014
Supervised segmentation of polycystic kidneys: a new application for stereology data. Journal of digital imaging\| PubMed ID: 24639063	2014
Phosphodiesterase 1A modulates cystogenesis in zebrafish. Journal of the American Society of Nephrology : JASN\| PubMed ID: 24700876	2014
Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. The Journal of clinical investigation\| PubMed ID: 24892705	2014
Filling the holes in cystic kidney disease research. Clinical journal of the American Society of Nephrology : CJASN\| PubMed ID: 24903391	2014
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. Journal of the American Society of Nephrology : JASN\| PubMed ID: 24904092	2015
Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model. Journal of the American Society of Nephrology : JASN\| PubMed ID: 24994926	2015
Liver involvement in early autosomal-dominant polycystic kidney disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association\| PubMed ID: 25111236	2015
Angiotensin blockade in late autosomal dominant polycystic kidney disease. The New England journal of medicine\| PubMed ID: 25399731	2014
Blood pressure in early autosomal dominant polycystic kidney disease. The New England journal of medicine\| PubMed ID: 25399733	2014
Novel therapeutic approaches to autosomal dominant polycystic kidney disease. Translational research : the journal of laboratory and clinical medicine\| PubMed ID: 25438190	2015
Identification of Biomarkers for PKD1 Using Urinary Exosomes. Journal of the American Society of Nephrology : JASN\| PubMed ID: 25475747	2014
Vasopressin receptor antagonists, heart failure, and polycystic kidney disease. Annual review of medicine\| PubMed ID: 25493947	2015
Effects of hydration in rats and mice with polycystic kidney disease. American journal of physiology. Renal physiology\| PubMed ID: 25503729	2015
The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. Clinical and experimental nephrology\| PubMed ID: 25663351	2015
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international\| PubMed ID: 25786098	2015
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease. Kidney international\| PubMed ID: 25830764	2015
Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nature reviews. Nephrology\| PubMed ID: 25870007	2015
The Future of Polycystic Kidney Disease Research-As Seen By the 12 Kaplan Awardees. Journal of the American Society of Nephrology : JASN\| PubMed ID: 25952256	2015
Utilizing magnetization transfer imaging to investigate tissue remodeling in a murine model of autosomal dominant polycystic kidney disease. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine\| PubMed ID: 25974140	2015
Volume regression of native polycystic kidneys after renal transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association\| PubMed ID: 26044834	2015
Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC). American journal of kidney diseases : the official journal of the National Kidney Foundation\| PubMed ID: 26088508	2015